Abstract
Studies on the association between sequence variability of the interferon sensitivity-determining region (ISDR) of hepatitis C virus and the outcome of treatment have reached conflicting results. In this study, 25 patients infected with HCV 6a who had received interferon-alpha/ribavirin combination treatment were analyzed for the sequence variations. 14 of them had the full genome sequences obtained from a previous study, whereas the other 11 samples were sequenced for the extended ISDR (eISDR). This eISDR fragment covers 192 bp (64 amino acids) upstream and 201 bp (67 amino acids) downstream from the ISDR previously defined for HCV 1b. The comparison between interferon-alpha resistance and response groups for the amino acid mutations located in the full genome (6 and 8 patients respectively) as well as the mutations located in the eISDR (10 and 15 patients respectively) showed that the mutations I2160V, I2256V, V2292I (P<0.05) within eISDR were significantly associated with resistance to treatment. However, the extent of amino acid variations within previously defined ISDR was not associated with resistance to treatment as previously reported. Four amino acid variations I248V (P=0.03-0.06) within E1, R445K (P=0.02-0.05) and S7...Continue Reading
References
Jul 1, 1995·The Journal of Clinical Investigation·N EnomotoC Sato
Jan 11, 1996·The New England Journal of Medicine·N EnomotoC Sato
Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S ZeuzemW K Roth
Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D Herion, J H Hoofnagle
Jul 18, 1997·Biochemical and Biophysical Research Communications·A TanimotoR Padmanabhan
Oct 23, 1997·Journal of Medical Virology·W T HofgärtnerD R Gretch
Jun 20, 1998·The Journal of General Virology·G DuverlieC Wychowski
Sep 17, 1999·The Journal of Biological Chemistry·K E Reed, C M Rice
Oct 12, 1999·Intervirology·R SuzukiT Miyamura
Dec 22, 1999·Journal of Viral Hepatitis·J M Pawlotsky, G Germanidis
Nov 25, 2000·Liver·P HalfonG Cartouzou
May 16, 2001·Virology·S L Tan, M G Katze
Jul 7, 2001·The New England Journal of Medicine·G M Lauer, B D Walker
May 30, 2002·Virology·Sophie GirardLaura Beretta
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Mar 28, 2003·The Journal of Infectious Diseases·Chee-Kin HuiChing-Lung Lai
Aug 3, 2004·Nature Biotechnology·Sean R Eddy
Jun 30, 2005·Journal of Viral Hepatitis·M DerbalaM El Ghannam
Jul 21, 2005·Journal of Medical Virology·F Legrand-AbravanelJacques Izopet
Sep 17, 2005·Intervirology·Nancy LeungJohn S Tam
Sep 17, 2005·Intervirology·Man-Fung Yuen, Ching-Lung Lai
Citations
Jul 16, 2013·Archives of Virology·Saba KhaliqShah Jahan
Jan 6, 2012·World Journal of Gastroenterology : WJG·Xiao-Ming ZhouJohn S Tam
Oct 12, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donald B SmithPeter Simmonds
Jun 3, 2015·Alimentary Pharmacology & Therapeutics·J A HolmesA J Thompson
Sep 28, 2013·World Journal of Hepatology·Chalermrat BunchorntavakulTawesak Tanwandee